Quarterly Snapshot: Quick and Current Ratios for PMV Pharmaceuticals Inc (PMVP)

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The closing price of PMV Pharmaceuticals Inc (NASDAQ: PMVP) was $1.70 for the day, up 2.41% from the previous closing price of $1.66. In other words, the price has increased by $2.41 from its previous closing price. On the day, 0.84 million shares were traded. PMVP stock price reached its highest trading level at $1.8 during the session, while it also had its lowest trading level at $1.62.


Our analysis of PMVP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 16.79 and its Current Ratio is at 16.79. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on May 13, 2024, initiated with a Buy rating and assigned the stock a target price of $6.

On April 12, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $5.

On December 27, 2023, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $7.Ladenburg Thalmann initiated its Buy rating on December 27, 2023, with a $7 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 22 ’23 when ORBIMED ADVISORS LLC sold 87,786 shares for $2.23 per share. The transaction valued at 195,763 led to the insider holds 0 shares of the business.

Alland Leila sold 6,291 shares of PMVP for $41,646 on Sep 15 ’23. The Chief Medical Officer now owns 45,909 shares after completing the transaction at $6.62 per share. On Sep 15 ’23, another insider, Jalota Deepika, who serves as the Chief Development Officer of the company, sold 4,104 shares for $6.62 each. As a result, the insider received 27,168 and left with 29,946 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMVP now has a Market Capitalization of 87453952 and an Enterprise Value of -97463072.

Stock Price History:

Over the past 52 weeks, PMVP has reached a high of $9.72, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is -7.54%, while the 200-Day Moving Average is calculated to be -38.26%.

Shares Statistics:

PMVP traded an average of 550.49K shares per day over the past three months and 523760 shares per day over the past ten days. A total of 51.45M shares are outstanding, with a floating share count of 43.56M. Insiders hold about 15.32% of the company’s shares, while institutions hold 78.16% stake in the company. Shares short for PMVP as of 1715731200 were 2571373 with a Short Ratio of 4.67, compared to 1713139200 on 2781533. Therefore, it implies a Short% of Shares Outstanding of 2571373 and a Short% of Float of 5.87.

Most Popular